Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.

MLA

Robles, Claudia, et al. “Impact of the COVID-19 Pandemic on Cervical Cancer Screening Participation, Abnormal Cytology Prevalence and Screening Interval in Catalonia.” Frontiers in Oncology, June 2024, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fonc.2024.1338859.

APA

Robles, C., Monfil, L., Ibáñez, R., Roura, E., Font, R., Peremiquel-Trillas, P., Brotons, M., Martínez-Bueno, C., de Sanjosé, S., Espinàs, J. A., & Bruni, L. (2024). Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia. Frontiers in Oncology, 1–9. https://doi.org/10.3389/fonc.2024.1338859

Chicago

Robles, Claudia, Laura Monfil, Raquel Ibáñez, Esther Roura, Rebeca Font, Paula Peremiquel-Trillas, Maria Brotons, et al. 2024. “Impact of the COVID-19 Pandemic on Cervical Cancer Screening Participation, Abnormal Cytology Prevalence and Screening Interval in Catalonia.” Frontiers in Oncology, June, 1–9. doi:10.3389/fonc.2024.1338859.